Gritstone bio (GRTS) Revenue & Revenue Breakdown
Gritstone bio Revenue Highlights
Latest Revenue (Y)
$16.34M
Latest Revenue (Q)
$49.00K
Main Segment (Y)
Grant
Gritstone bio Revenue by Period
Gritstone bio Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $16.34M | 76.33% |
2022-12-31 | $9.27M | -80.16% |
2021-12-31 | $46.72M | 1057.22% |
2020-12-31 | $4.04M | -7.51% |
2019-12-31 | $4.37M | 267.73% |
2018-12-31 | $1.19M | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | - |
Gritstone bio Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $49.00K | 68.97% |
2023-12-31 | $29.00K | -98.15% |
2023-09-30 | $1.56M | 291.25% |
2023-06-30 | $400.00K | -26.20% |
2023-03-31 | $542.00K | -59.16% |
2022-12-31 | $1.33M | 204.36% |
2022-09-30 | $436.00K | -84.21% |
2022-06-30 | $2.76M | -41.81% |
2022-03-31 | $4.75M | 166.57% |
2021-12-31 | $1.78M | -25.86% |
2021-09-30 | $2.40M | -15.55% |
2021-06-30 | $2.84M | -92.84% |
2021-03-31 | $39.69M | 2842.40% |
2020-12-31 | $1.35M | 43.66% |
2020-09-30 | $939.00K | 92.42% |
2020-06-30 | $488.00K | -61.33% |
2020-03-31 | $1.26M | 42.76% |
2019-12-31 | $884.00K | -10.16% |
2019-09-30 | $984.00K | -14.43% |
2019-06-30 | $1.15M | -14.63% |
2019-03-31 | $1.35M | 23.46% |
2018-12-31 | $1.09M | 1036.46% |
2018-09-30 | $96.00K | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | - |
Gritstone bio Revenue Breakdown
Gritstone bio Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
---|---|---|---|---|
Collaboration Revenue | $300.00K | - | - | - |
License | $1.33M | $9.27M | $46.72M | $3.46M |
Grant | $15.01M | $10.68M | $1.50M | - |
Contribution | - | - | - | $575.00K |
Latest
Quarterly Revenue by Product
Product/Service | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Dec 20 | Sep 20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
License | $57.00K | $49.00K | $389.00K | $400.00K | $542.00K | $1.33M | $436.00K | $2.76M | $4.75M | $1.78M | $2.40M | $918.00K | $795.00K |
Grant | $864.00K | $1.69M | $11.56M | $1.55M | $1.90M | $2.94M | $2.58M | $2.71M | $2.45M | $1.28M | $213.00K | - | - |
Contribution | - | - | - | - | - | - | - | - | - | - | - | $431.00K | $144.00K |
Latest
Gritstone bio Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
SGMO | Sangamo Therapeutics | $176.23M | $356.00K |
AUPH | Aurinia Pharmaceuticals | $158.53M | $57.19M |
HRTX | Heron Therapeutics | $127.04M | $36.02M |
GTHX | G1 Therapeutics | $82.51M | $16.55M |
ADAP | Adaptimmune Therapeutics | $60.28M | $128.23M |
GRTS | Gritstone bio | $16.34M | $49.00K |
BBIO | BridgeBio Pharma | $9.30M | $2.17M |
AFMD | Affimed | $8.28M | $155.00K |
KZR | Kezar Life Sciences | $7.00M | - |
KRON | Kronos Bio | $6.29M | $2.37M |
GBIO | Generation Bio | $5.90M | $4.09M |
FULC | Fulcrum Therapeutics | $2.81M | - |
ALLO | Allogene Therapeutics | $95.00K | - |
IFRX | InflaRx | $61.80K | $36.25K |
CRVS | Corvus Pharmaceuticals | - | - |
APTO | Aptose Biosciences | - | - |
CCCC | C4 Therapeutics | - | - |
LPTX | Leap Therapeutics | - | - |
ERAS | Erasca | - | - |
ANNX | Annexon | - | - |
PASG | Passage Bio | - | - |
ANVS | Annovis Bio | - | - |
EWTX | Edgewise Therapeutics | - | - |